Genscript Biotech Stock Analysis

Genscript Pink Sheet Analysis Notes

About 38.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 200.0. Genscript Biotech recorded a loss per share of 0.17. The entity last dividend was issued on the 5th of June 2017. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.The quote for Genscript Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Genscript Biotech call Brian Min at 86 25 5889 7288 or check out https://www.genscript.com.

Genscript Biotech Investment Alerts

Genscript Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genscript Biotech's market, we take the total number of its shares issued and multiply it by Genscript Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Genscript Profitablity

The company has Profit Margin (PM) of (0.66) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64.

Technical Drivers

As of the 26th of November, Genscript Biotech retains the Standard Deviation of 2.1, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of 0.7835. Genscript Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genscript Biotech variance and value at risk to decide if Genscript Biotech is priced fairly, providing market reflects its last-minute price of 1.37 per share. Given that Genscript Biotech is a hitting penny stock territory we urge to closely look at its jensen alpha.

Genscript Biotech Price Movement Analysis

Genscript Biotech Predictive Daily Indicators

Genscript Biotech Forecast Models

Genscript Biotech's time-series forecasting models are one of many Genscript Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genscript Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Genscript Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genscript shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Genscript Biotech. By using and applying Genscript Pink Sheet analysis, traders can create a robust methodology for identifying Genscript entry and exit points for their positions.

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.